Table 5.
Baseline µCT parameters of treatment groups
| Potassium Citrate (n=12) | Potassium Chloride (n=8) | P | |
|---|---|---|---|
| BV/TV, % | 22.9±3.2 | 17.9±3.4 | 0.07 |
| BS/BV, 1/mm | 19.5±4.5 | 23.5±4.0 | 0.06 |
| Trabecular thickness, 1/mm | 0.15±0.31 | 0.13±0.22 | 0.13 |
| Trabecular separation, mm | 0.64±0.12 | 0.61±0.09 | 0.71 |
| Trabecular number, 1/mm3 | 1.57±0.25 | 1.65±0.27 | 0.51 |
| Connectivity density, 1/mm | 11.9±9.2 | 14.7±7.5 | 0.49 |
| BMD, mg/HA cm3 | 261±72 | 204±40 | 0.06 |
| BMD1, mg/HA cm3 | 932±27 | 927±28 | 0.71 |
| Time between biopsies, mo | 14.5±3.8 | 13.1±1.0 | 0.31 |
µCT, micro-computed tomography; BV, bone volume; TV, total volume; BS, bone surface; BMD, bone mineral density.